A phase III randomised trial of lobectomy versus limited resection (segmentectomy) for small (2 cm or less) peripheral non-small cell lung cancer (JCOG0802/WJOG4607L)
Phase 3
- Conditions
- small (2 cm or less) peripheral non-small cell lung cancer
- Registration Number
- JPRN-UMIN000002317
- Lead Sponsor
- Japan Clinical Oncology Group(JCOG)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1319
Inclusion Criteria
Not provided
Exclusion Criteria
1) Active bacterial or fungous infection. 2) Simultaneous or metachronous (within the past 5 years) double cancers. 3) Women during pregnancy or breast-feeding. 4) Interstitial pneumonitis, pulmonary fibrosis, or severe pulmonary emphysema. 5) Psychosis. 6) Systemic steroids medication. 7) Uncontrollable diabetes mellitus. 8) Uncontrollable hypertension. 9) History of severe heart disease, heart failure, myocardial infarction within the past 6 months or attack of angina pectoris within the past 6 months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method overall survival
- Secondary Outcome Measures
Name Time Method postoperative respiratory function, relapse-free survival, proportion of local recurrence, adverse events, proportion of completion of segmentectomy, days of hospitalization, duration of chest tube placement, operation time, blood loss, number of used auto-sutures.